Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,266 signal articles · 40 in last 24h · 115,327 total before filter · latest 2h ago
40last 24h
1796last 7d
300● bullish (7d)
170● bearish (7d)
205publishers
AllMacro318Earnings843M&A103Regulatory25Product16Analyst25
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearishshow all (incl. clickbait)
Bloomberg10d agobearish
Bezos Cuts Amazon Stake by $350 Million in Year’s First Sale

(Bloomberg) -- Jeff Bezos unloaded almost $350 million in Amazon.com Inc. stock as it hit a record on Monday, his first sale of the company’s shares this year.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanSpaceX’s AI Splurge Puts a Damper on First Earnings After IPOTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallThe transaction,

Investing.com10d agobearish
AppLovin stock plunges 20% as top-line miss and soft guidance overshadow profit

Investing.com -- AppLovin Corporation (NASDAQ: APP) saw its shares crater 20% after delivering second-quarter results that proved sky-high profit growth isn’t always enough for Wall Street. Despite surging year-over-year earnings, the marketing software titan missed sales targets and issued a lukewarm forecast for the quarter ahead.

DoorDash Profit Falls as Costs Offset Revenue Growth
The Wall Street Journal10d agobearish
DoorDash Profit Falls as Costs Offset Revenue Growth

The decline in profit was driven by higher costs of revenue from more orders, as well as increases in sales, marketing, and research and development expenses and other overhead costs, the company said.

SpaceX Stock Drops on Ballooning AI Bill
The Wall Street Journal10d agobearish
SpaceX Stock Drops on Ballooning AI Bill

SpaceX shares dropped 14%. Elon Musk’s space company late Tuesday said its capital expenditures topped $18 billion last quarter, double the previous quarter’s total, mainly tied to its artificial-intelligence build-out. AMD shares also fell 7% after Musk said SpaceX would exclusively use chips from rival Nvidia, shares of which gained 4%.

Flutter Stock Tumbles as FanDuel Betting Growth Slows
Barrons.com10d agobearish
Flutter Stock Tumbles as FanDuel Betting Growth Slows

Flutter Entertainment announced the resignation of its longtime CEO Peter Jackson when it reported second-quarter earnings on Wednesday. Despite a nine-year tenure that saw Flutter grow from a $2 billion U.K.-focused business to a $16 billion international betting titan, Jackson isn’t going out on a high note. Shares of the world’s largest betting firm and FanDuel parent company were down as much as 14% Wednesday after the firm reported mixed results and reduced its full-year guidance.

Uber Stock Falls After Softer Profit Outlook
The Wall Street Journal10d agobearish
Uber Stock Falls After Softer Profit Outlook

Shares of Uber Technologies fell 6% in midday trading Wednesday after the ride-hailing company issued a softer-than-expected outlook for the current quarter. Uber reported quarterly revenue of $14.19 billion, up 12% from a year earlier amid an increase in both rides and deliveries. For the current quarter, Uber forecast adjusted earnings of 84 cents to 88 cents a share, compared with analyst expectations of 87 cents a share.

AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation
InvestorsHub10d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation

AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are “no discussions” between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The report eased concerns surrounding a deal that, if completed, would have created a pharmaceutical group valued at close to $400 billion.